Emerging Stocks Down Under 5 January 2021: Zelira Therapeutics, Ecograf, IntelliHR

Zelira Therapeutics: Awake to the insomnia opportunity

In today’s edition of Emerging Stocks Down Under, if you can’t get to sleep because the market has gone against you, then take a look at the Perth-based Zelira Therapeutics. This medicinal cannabis company has insomnia as its lead indication, followed by a second major opportunity in autism. With cannabis stocks now back in favour, we believe this one will be getting high.

Also in today’s edition, a look at graphite technology developer Ecograf (ASX: EGR) and HR system developer IntelliHR (ASX: IHR).

Get access to all editions through a 30-day FREE TRIAL. No credit card required and the trial expires automatically.

GET A 30-DAY FREE TRIAL

Click here to read the previous edition of Emerging Stocks Down Under published 29 December 2020

For in-depth research reports or to keep up-to-date on the latest Stocks Down Under news see our parent company, Pitt Street Research, or follow us on Facebook and Twitter